Psoriatic arthritis (PsA) is a chronic, progressive arthropathy with heterogeneous clinical presentations. Between 40% and 60% of patients develop erosive and deforming joint complications and pain, impacting their mobility, productivity and physical and psychosocial health-related quality of life.
Current treatment goals for PsA aim to relieve pain, preserve joint structure, improve physical activity and reduce mortality. Conventional treatment options include nonsteroidal anti-inflammatory drugs, intra-articular steroid injections and disease-modifying anti-rheumatic drugs. As the number and diversity of effective targeted treatment options for PsA continue to increase, so do opportunities and challenges in choosing the appropriate therapeutic approach for each individual patient.
To address current clinical challenges, the Warren Alpert Medical School of Brown University, Office of Continuing Medical Education and Catamount Medical Education have developed PATIENTGPS™: Clinical Paths in the Diagnosis and Personalized Treatment of Psoriatic Arthritis.
As a follow up to the successful live meeting series, you can now participate in an interactive online learning activity presented by Robin K. Dore, MD, Professor of Medicine at David School of Medicine, UCLA by clicking the button below.
This CME activity is jointly provided by Brown University and Catamount Medical Education.